PA
DICE

Perceptive Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Perceptive Advisors’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-293,362
Closed -$9.15M – 111
2022
Q4 		$9.15M Sell
293,362
-394,062
-57% -$12.9M 0.26% 63
2022
Q3 		$13.9M Sell
687,424
-364,480
-35% -$6.64M 0.4% 58
2022
Q2 		$16.3M Sell
1,051,904
-463,457
-31% -$7.97M 0.51% 44
2022
Q1 		$29M Buy
1,515,361
+810,476
+115% +$14.5M 0.58% 44
2021
Q4 		$17.8M Buy
+704,885
New +$20.7M 0.28% 73

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Perceptive Advisors's DICE Position: Q1 2023 in Review

Perceptive Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2023, closing a stake of 293,362 shares — an estimated $9.15M sold.

Perceptive Advisors first reported a position in DICE in Q4 2021 and held it in 5 quarters. The position peaked at $29M in Q1 2022. 115 funds tracked by Wall St. Rank hold DICE as of Q1 2023.

  • Perceptive Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Perceptive Advisors sold 293,362 DICE Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $9.15M.
  • Perceptive Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Perceptive Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $29M in Q1 2022.
  • 115 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.